Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
The European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy is proud to present an engaging and interactive course to improve the professional knowledge and skills for cardiovascular pharmacotherapy in older patients.
In Europe and the Western World in particular, the proportion of older persons is dramatically increasing, which is predicted to add tremendous extra pressure to the strained health care systems.
Cardiovascular drugs are among the most prevalent drugs administered to older people. In particular diuretics, antihypertensives, NOACs, antiarrhythmics, lipid lowering drugs and glucose lowering drugs. All these drug classes can lead to increased frailty and should in particular not be prescribed on a one-size-fits-all-basis to older people, and polypharmacy should be countered.
Our goal is for all participants to leave the meeting with the improved competence and confidence to deliver better, personalized therapy of older people, which in turn will have a positive impact on services and patient outcomes.
Access the slides from the speakers
Juan Carlos Kaski, MD, DSc, FESC
Keld Kjeldsen, MD, DSc
Heinz Drexel, MD, DSc, FESC
This educational programme is accredited for 5 CME Credit(s). Each participant should claim only those hours of credits that have actually been spent in the educational activity.
Find out more about CME and accreditation.
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, FR
London, United Kingdom
This course is supported with an educational grant by Daiichi Sankyo and the Bristol-Myers Squibb and Pfizer Alliance.
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.